Wang P, Ba Z F, Cioffi W G, Bland K I, Chaudry I H
Center for Surgical Research and Department of Surgery, Brown University School of Medicine and Rhode Island Hospital, Providence 02903, USA.
Arch Surg. 1998 Dec;133(12):1298-304. doi: 10.1001/archsurg.133.12.1298.
Initial cardiovascular responses during sepsis are characterized by hyperdynamic circulation. Although studies have shown that a novel potent vasodilatory peptide, adrenomedullin (ADM), is up-regulated under such conditions, it remains unknown whether ADM is responsible for initiating the hyperdynamic response.
To determine whether increased ADM release during early sepsis plays any major role in producing hyperdynamic circulation. DESIGN, INTERVENTION, AND MAIN OUTCOME MEASURE: Synthetic rat ADM (8.5 microg/kg of body weight) was infused intravenously in normal rats for 15 minutes at a constant rate. Cardiac output, stroke volume, and microvascular blood flow in various organs were determined immediately as well as 30 minutes after ADM infusion. At 30 minutes after infusion, plasma ADM level was also measured. In additional groups, rats were subjected to sepsis by cecal ligation and puncture. At 1.5 hours after cecal ligation and puncture, specific anti-rat ADM antibodies were infused, which completely neutralized the circulating ADM. Various hemodynamic variables were measured 5 hours after cecal ligation and puncture (ie, the early stage of sepsis).
Cardiac output, stroke volume, and microvascular blood flow in the liver, small intestine, kidney, and spleen increased, and total peripheral resistance decreased 0 and 30 minutes after ADM infusion. In addition, plasma levels of ADM increased from the preinfusion level of 92.7+/-5.3 to 691.1+/-28.2 pg/mL 30 minutes after ADM infusion, which was similar to ADM levels observed during early sepsis. Moreover, 5 hours after the onset of sepsis, cardiac output, stroke volume, and microvascular blood flow in various organs increased and total peripheral resistance decreased. Administration of anti-ADM antibodies, however, prevented the occurrence of the hyperdynamic response.
The results suggest that increased ADM production and/or release plays a major role in producing hyperdynamic responses during early sepsis. Since our previous studies have shown that vascular responsiveness to ADM decreases in late sepsis, maintenance of ADM vascular responsiveness by pharmacological agents during the course of sepsis may prevent transition from the hyperdynamic to the hypodynamic state.
脓毒症期间的初始心血管反应以高动力循环为特征。尽管研究表明,一种新型强效血管舒张肽——肾上腺髓质素(ADM)在这种情况下会上调,但ADM是否引发高动力反应仍不清楚。
确定脓毒症早期ADM释放增加是否在产生高动力循环中起主要作用。设计、干预及主要观察指标:以恒定速率将合成大鼠ADM(8.5微克/千克体重)静脉输注到正常大鼠体内15分钟。在ADM输注后即刻及30分钟测定心输出量、每搏输出量和各器官的微血管血流量。在输注30分钟后,还测量血浆ADM水平。在其他组中,通过盲肠结扎和穿刺使大鼠发生脓毒症。在盲肠结扎和穿刺后1.5小时,输注特异性抗大鼠ADM抗体,其可完全中和循环中的ADM。在盲肠结扎和穿刺后5小时(即脓毒症早期)测量各种血流动力学变量。
ADM输注后0和30分钟,心输出量、每搏输出量以及肝脏、小肠、肾脏和脾脏的微血管血流量增加,总外周阻力降低。此外,ADM输注30分钟后,血浆ADM水平从输注前的92.7±5.3皮克/毫升升至691.1±28.2皮克/毫升,这与脓毒症早期观察到的ADM水平相似。此外,脓毒症发作5小时后,各器官的心输出量、每搏输出量和微血管血流量增加,总外周阻力降低。然而,给予抗ADM抗体可防止高动力反应的发生。
结果表明,ADM产生和/或释放增加在脓毒症早期产生高动力反应中起主要作用。由于我们之前的研究表明,脓毒症晚期血管对ADM的反应性降低,在脓毒症病程中通过药物维持ADM血管反应性可能防止从高动力状态转变为低动力状态。